Bio-Path Holdings, Inc. (BPTH)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Nov 9, 2026
Bio-Path Holdings Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
16.17K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ObsEva | 19.64M |
| Statera Biopharma | 3.69M |
| Scorpius Holdings | 1.72M |
| GeneLink | 1.58M |
| Trevena | 546.00K |
| Syros Pharmaceuticals | 386.00K |
| Health Sciences Group | 69.31K |
Bio-Path Holdings News
- 5 months ago - Bio-Path Holdings Quarterly report: Q1 2026 - Filings
- 8 months ago - Biotech Alert: Searches spiking for these stocks today - TheFly
- 9 months ago - Biotech Alert: Searches spiking for these stocks today - TheFly
- 9 months ago - Biotech Alert: Searches spiking for these stocks today - TheFly
- 10 months ago - Bio-Path Holdings Quarterly report: Q3 2025 - Filings
- 1 year ago - Bio-Path Holdings Quarterly report: Q2 2025 - Filings
- 1 year ago - Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 25 - Newsfile Corp
- 1 year ago - Bio-Path price target lowered to $2 from $9 at Roth Capital - TheFly